Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.
Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.
Researchers sought to determine patient and visit characteristics associated with the discussion of postmenopausal vulvovaginal symptoms at well-woman examinations.